Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Table 4

Baseline levels of fasting glycemia and impaired fasting glucose or type 2 diabetes mellitus prevalence according to treatment experience.

	Naïve; Absolute (relative); counts or mean±SEM	Treatment experienced; Absolute (relative); counts or mean±SEM	P
All patients
Glycemia (mmol/L)	5.71±0.15	6.41±0.16	0.006
IFG	19 (17.1)	74 (28.6)	0.008
T2DM	23 (20.7)	65 (25.1)	0.411
IFG or T2DM	42 (37.8)	139 (53.7)	0.005
Only F4 fibrosis patients
Glycemia (mmol/L)	6.16±0.23	6.86±0.26	0.637
IFG	10 (23.3)	36 (28.3)	0.535
T2DM	13 (30.2)	41 (32.3)	0.921
IFG or T2DM	23 (53.5)	77 (60.6)	0.411